Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens
Adrien Bosseboeuf, Delphine Feron, Anne Tallet, Cédric Rossi, Cathy Charlier, Laurent Garderet, Denis Caillot, Philippe Moreau, Marina Cardó-Vila, Renata Pasqualini, Wadih Arap, Alfreda Destea Nelson, Bridget S. Wilson, Hélène Perreault, Eric Piver, Pierre Weigel, François Girodon, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet
Adrien Bosseboeuf, Delphine Feron, Anne Tallet, Cédric Rossi, Cathy Charlier, Laurent Garderet, Denis Caillot, Philippe Moreau, Marina Cardó-Vila, Renata Pasqualini, Wadih Arap, Alfreda Destea Nelson, Bridget S. Wilson, Hélène Perreault, Eric Piver, Pierre Weigel, François Girodon, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet
View: Text | PDF
Research Article Immunology

Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens

  • Text
  • PDF
Abstract

Subsets of mature B cell neoplasms are linked to infection with intracellular pathogens such as Epstein-Barr virus (EBV), hepatitis C virus (HCV), or Helicobacter pylori. However, the association between infection and the immunoglobulin-secreting (Ig-secreting) B proliferative disorders remains largely unresolved. We investigated whether the monoclonal IgG (mc IgG) produced by patients diagnosed with monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM) targets infectious pathogens. Antigen specificity of purified mc IgG from a large patient cohort (n = 244) was determined using a multiplex infectious-antigen array (MIAA), which screens for reactivity to purified antigens or lysates from 9 pathogens. Purified mc IgG from 23.4% of patients (57 of 244) specifically recognized 1 pathogen in the MIAA. EBV was the most frequent target (15.6%), with 36 of 38 mc IgGs recognizing EBV nuclear antigen-1 (EBNA-1). MM patients with EBNA-1–specific mc IgG (14.0%) showed substantially greater bone marrow plasma cell infiltration and higher β2-microglobulin and inflammation/infection–linked cytokine levels compared with other smoldering myeloma/MM patients. Five other pathogens were the targets of mc IgG: herpes virus simplex-1 (2.9%), varicella zoster virus (1.6%), cytomegalovirus (0.8%), hepatitis C virus (1.2%), and H. pylori (1.2%). We conclude that a dysregulated immune response to infection may underlie disease onset and/or progression of MGUS and MM for subsets of patients.

Authors

Adrien Bosseboeuf, Delphine Feron, Anne Tallet, Cédric Rossi, Cathy Charlier, Laurent Garderet, Denis Caillot, Philippe Moreau, Marina Cardó-Vila, Renata Pasqualini, Wadih Arap, Alfreda Destea Nelson, Bridget S. Wilson, Hélène Perreault, Eric Piver, Pierre Weigel, François Girodon, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet

×

Figure 8

H.pylori–specific mc IgGs as determined by the MIAA assay.

Options: View larger image (or click on image) Download as PowerPoint

H.pylori–specific mc IgGs as determined by the MIAA assay.
 (A) Results...
(A) Results of the multiplex infectious-antigen array (MIAA) assay for the 3 patients with a H. pylori–specific monoclonal (mc) IgG. For each patient, the results obtained for H. pylori lysate 1 and lysate 2 with the patient’s serum (S) and purified mc IgG are shown. (B) The results obtained for patient P186 are detailed: serum P186 contained IgG that recognized CMV, EBV nuclear antigen-1 (EBNA-1), EBV viral capsid protein (VCA), H. pylori, herpes simplex virus-1 (HSV-1), HSV-2, T. gondii, and varicella zoster virus (VZV) ORF-26, whereas the purified mc IgG recognized only the H. pylori lysates (dark green: mix of lysates 1 and 2; medium green: lysate 1; light green: lysate 2). Note that certain H. pylori proteins and Ags are likely present both in lysate 1 and lysate 2. The fluorescence values shown for each pathogen, Ag, or lysate were obtained after subtraction of the threshold of specific positivity of the pathogen, Ag, or lysate (500 for H. pylori). Dots may be superimposed; horizontal bars represent the mean of results obtained for a pathogen, Ag, or lysate. Experiments were performed at least twice. (C) The immunoblot assay was performed using the commercial kit Helico Blot 2.1 (MP Biomedicals), which consisted of a Western blot made from bacterial lysate of H. pylori strain ATCC 49503. The test strip contained H. pylori Ags with molecular weights of 116 kDa (CagA), 89 kDa (VacA), 65 kDa (urease B), 60 kDa (heat shock protein [HSP]), 37 kDa (H. pylori undetermined protein [UP]), 35 kDa (H. pylori UP), and 30 kDa (urease A) as separate bands. The assay was performed and interpreted according to the instructions of the manufacturers. Experiments were performed at least twice.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts